Researchers have discovered that physical pressure—specifically the mechanical forces within biofilms—can help the opportunistic pathogen Pseudomonas aeruginosa withstand antibiotic treatment. The pathogen is a leading cause of hospital-acquired infections and a major threat to people with cystic fibrosis.
This finding challenges conventional understanding of antibiotic resistance, which typically focuses on genetic mutations or biochemical defenses. The study highlights how the physical environment of an infection can itself shield bacteria from drugs, offering a new avenue for therapeutic intervention.
Published in a recent study, the research showed that P. aeruginosa cells exposed to compressive stress, similar to pressure in mucus-filled lungs or medical devices, became more tolerant to antibiotics. The effect was observed across multiple classes of drugs, including ciprofloxacin and tobramycin.
These results suggest that treatment strategies may need to account for physical forces at infection sites. For cystic fibrosis patients, whose lungs feature thick mucus that exerts constant pressure, this could mean revisiting how antibiotics are delivered or combined with other therapies.
The study's authors note that further work is needed to determine how to disrupt this mechanical protection without harming host tissues. Countering this effect might involve new drug formulations or devices that alter the local pressure environment.